New Publications

We constantly update the database in order to offer our customers the broadest possible choice of market research reports and meet all their needs. Browse the most recent publications below.


Construction of Telecommunications Lines and Systems & Electric Power Lines and Systems Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021,... US$ 1,995.00

... , benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. KEY FINDINGS: Construction of Telecommunications Lines and Systems & Electric Power Lines and Systems Industry (U.S.) to reach $51.9 billion by 2021. New Study offers Complete Benchmarking and Metrics ...

Jul, 2014 67 pages
Construction of Railways, Marine Facilities, and Subways Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 237990 US$ 1,995.00

... including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. KEY FINDINGS: Construction of Railways, Marine Facilities, and Subways Industry (U.S.) to reach $22.3 billion by 2021. New Study offers Complete Benchmarking and Metrics of the U.S. ...

Jul, 2014 42 pages
Construction (Building) Industry, Including the Construction of Residential Homes and Apartments, Commercial Buildings, and Industrial Buildings Industry (U.S.): Analytics, Extensive... US$ 1,995.00

... . New Study offers Complete Benchmarking and Metrics of the U.S. Construction (Building) Industry, including Average EBITDA, Operating Ratios and Sales per ... and Private) Companies Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2013 Income Statements. Balance Sheets and Cash Flow ...

Jul, 2014 61 pages
2014 Deep Research Report on Global and China Mobile Phone Charger Industry US$ 2,200.00

2014 Deep Research Report on Global and China Mobile Phone Charger Industry was professional and depth research report on Global and ... application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis ...

Jul, 2014 265 pages
2014 Deep Research Report on Global and China Ammonium Bicarbonate Industry US$ 2,200.00

2014 Deep Research Report on Global and China Ammonium Bicarbonate Industry was professional and depth research report on Global and China Ammonium Bicarbonate industry. The report firstly introduced Ammonium Bicarbonate basic information included Ammonium Bicarbonate ...

Jul, 2014 181 pages
Uruguay Water Report Q3 2014 US$ 1,295.00

... by economic uncertainty and limited private participation in the state owned and managed water sector. We believe other regional markets offer greater opportunities to private water management and infrastructure groups, and this will continue to attract investors away from Uruguay.

Jul, 2014 43 pages
Singapore Water Report Q3 2014 US$ 1,295.00

... Johor, Malaysia. The World Resources Institute (WRI) classed Singapore as in the 'extreme' category of water stress - putting it on a par with arid nations such as ... Kuwait. Evidence of this stress can be seen in the recent water shortages and threats of rationing which loomed in the first two months of 2014.

Jul, 2014 50 pages
Mauritius Insurance Report Q3 2014 US$ 1,295.00

... , Sub-Saharan Africa, Mauritius' insurance sector is well developed and has a number of obvious strengths. Nevertheless, as of mid-2014, the latest newsflow ... not a part of our forecasts. Credit for the stability of the overall insurance sector is due in part to the Financial Services Commission (FSC), which ...

Jul, 2014 65 pages
China Water Report Q3 2014 US$ 1,295.00

Includes 3 FREE quarterly updates BMI View: The ongoing widespread water pollution issues, in conjunction with the rising threat of long term water ... the Chinese government will increase the allocation for prevention and control of water pollution in major drainage areas to CNY500bn between 2011 and 2015, ...

Jul, 2014 57 pages
Angola Insurance Report Q3 2014 US$ 1,295.00

... Includes 3 FREE quarterly updates BMI View: As of mid-2014, it has become clear that Angola's insurance sector (which is dominated by the non-life ... precisely, the risks that need to be underwritten by the multinational companies in Angola's energy sector. However, it is also clear that non-life penetration ...

Jul, 2014 50 pages
Yes Tyrosine Kinase Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Yes Tyrosine Kinase Inhibitors pipeline on the basis of target, MOA, route of administration, technology ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Xanthine Oxidase Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“Xanthine Oxidase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Xanthine ...

Jul, 2014
Wnt Signaling Pathway Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... the understanding for all the pipeline drugs that fall under Wnt Signaling Pathway Inhibitors. This report provides information on the ... , development partner and chemical information Coverage of the Wnt Signaling Pathway Inhibitors pipeline on the basis of target, MOA, route of administration, technology ...

Jul, 2014
Wee1 Tyrosine Kinase inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Wee1 Tyrosine Kinase inhibitors pipeline on the basis of target, MOA, route of administration, technology ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Voltage-Gated Sodium Channel Blockers -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Voltage-Gated Sodium Channel Blockers pipeline on the basis of target, MOA, route of administration, ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Voltage-Dependent T-Type Calcium Channel Blockers -Pipeline Insights, 2014 US$ 1,250.00

... T-Type Calcium Channel Blockers Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision ... . Devise corrective measures for pipeline projects by understanding Voltage-Dependent T-Type Calcium Channel Blockers pipeline depth and focus of Indication therapeutics ...

Jul, 2014
Voltage-Dependent N-Type Calcium Channel Blockers -Pipeline Insights, 2014 US$ 1,250.00

... N-Type Calcium Channel Blockers Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision ... . Devise corrective measures for pipeline projects by understanding Voltage-Dependent N-Type Calcium Channel Blockers pipeline depth and focus of Indication therapeutics ...

Jul, 2014
Voltage-Dependent Calcium Channel Blockers -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Voltage-Dependent Calcium Channel Blockers pipeline on the basis of target, MOA, route of administration, ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Voltage-Dependent Calcium Channel Alpha-2/Delta Blockers -Pipeline Insights, 2014 US$ 1,250.00

... Channel Alpha-2/Delta Blockers and also provide company profiling The report also gives the information of dormant and discontinued pipeline ... corrective measures for pipeline projects by understanding Voltage-Dependent Calcium Channel Alpha-2/Delta Blockers pipeline depth and focus of Indication therapeutics ...

Jul, 2014
Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug development ...

Jul, 2014
Viral RNA Polymerase Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Viral RNA Polymerase Inhibitors pipeline on the basis of target, MOA, route of administration, technology ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Viral Protease Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... SUMMARY DelveInsight’s,“Viral Protease Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Viral DNA Polymerase Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Viral DNA Polymerase Inhibitors pipeline on the basis of target, MOA, route of administration, technology ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2014 US$ 1,250.00

... for all the pipeline drugs that fall under VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor. This report provides information ... report provides a snapshot of the global therapeutic landscape of VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor The report provides pipeline ...

Jul, 2014
Vasopressin V2 Receptor (V2R) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Vasopressin V2 Receptor (V2R) Antagonists pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug development activities. ...

Jul, 2014
Vasopressin V2 Receptor (V2R) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... use it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Vasopressin V2 Receptor (V2R) Agonists pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug development activities. ...

Jul, 2014
Vasopressin V1a Receptor (V1aR) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Vasopressin V1a Receptor (V1aR) Antagonists pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug development activities. ...

Jul, 2014
Vasopressin Receptor Antagonists -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“Vasopressin Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Vasopressin ...

Jul, 2014
Vasopressin Receptor Agonists -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“Vasopressin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Vasopressin Receptor ...

Jul, 2014
Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Vascular Endothelial Growth Factor A (VEGF-A) Activator -Pipeline Insights, 2014 US$ 1,250.00

... drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Vascular Endothelial Growth Factor A (VEGF-A) Activator pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Vascular Adhesion Protein 1 (VAP-1) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Vascular Adhesion Protein 1 (VAP-1) Inhibitors pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug development activities ...

Jul, 2014
UMP-CMP Kinase (UMP-CMPK) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the UMP-CMP Kinase (UMP-CMPK) Inhibitors pipeline on the basis of target, MOA, route of administration, ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Ubiquitin Specific Proteases (USP) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Ubiquitin Specific Proteases (USP) Inhibitors pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug development activities. ...

Jul, 2014
Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Tumor Necrosis Factor Receptor (TNFR) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... ). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Tumor Necrosis Factor Receptor ... . Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor Receptor (TNFR) Antagonists pipeline depth and focus of Indication therapeutics ...

Jul, 2014
Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... key players involved in the therapeutics development for Tumor Necrosis Factor Alpha (TNF-a) Agonists and also provide company profiling The ... . Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor Alpha (TNF-a) Agonists pipeline depth and focus of Indication therapeutics ...

Jul, 2014
Tumor Necrosis Factor (TNF) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... ). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Tumor Necrosis Factor (TNF) ... . Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor (TNF) Inhibitors pipeline depth and focus of Indication therapeutics Developing ...

Jul, 2014
Tumor Necrosis Factor (TNF) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Tumor ... . Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor (TNF) Agonists pipeline depth and focus of Indication therapeutics Developing ...

Jul, 2014
Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Trypsin Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“Trypsin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... for all the pipeline drugs that fall under TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists ... . Devise corrective measures for pipeline projects by understanding TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists ...

Jul, 2014
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... molecule type Reasons to buy Complete MOA intelligence and complete understanding over therapeutics development for Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonists Identify the relationship between the drugs and use it for target finding ...

Jul, 2014
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... molecule type Reasons to buy Complete MOA intelligence and complete understanding over therapeutics development for Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonists Identify the relationship between the drugs and use it for target finding, ...

Jul, 2014
Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... of development and molecule type Reasons to buy Complete MOA intelligence and complete understanding over therapeutics development for Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonists Identify the relationship between the drugs and use it for target finding, drug ...

Jul, 2014
Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... of development and molecule type Reasons to buy Complete MOA intelligence and complete understanding over therapeutics development for Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonists Identify the relationship between the drugs and use it for target finding, drug ...

Jul, 2014
Transglutaminase 2 Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“Transglutaminase 2 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Transglutaminase 2 ...

Jul, 2014
Skip to top